Old Mission Capital LLC Gilead Sciences, Inc. Transaction History

Old Mission Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $432,677 - $494,228	7,267 New	7,267 $448,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $2.14 Million - $2.69 Million	-37,003 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $2.4 Million - $2.72 Million	37,003 New	37,003 $2.69 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $448,038 - $546,208	-6,151 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $437,643 - $513,731	6,151	6,151 $441,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.